SCHEMBL8304210

SCHEMBL8304210

CC(=NOCCOc1ccc(CC2SC(=O)N(C(c3ccccc3)(c3ccccc3)c3ccccc3)C2=O)cc1)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.49
FFAR1 O14842 5/20 0.43
PPARA Q07869 2/20 0.40
S1PR1 P21453 2/20 0.40
CFTR P13569 1/20 0.38
MAOB P27338 1/20 0.35
PTGER4 P35408 1/20 0.34
BCL2 P10415 1/20 0.34
HTT P42858 1/20 0.34
PPARD Q03181 1/20 0.34
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304209 1.00 PPARG (0.49) PPARGFFAR1PPARAS1PR1CFTR
SCHEMBL8307060 0.94 PPARG (0.55) PPARGFFAR1S1PR1CFTRBCL2
SCHEMBL8307062 0.94 PPARG (0.55) PPARGFFAR1S1PR1CFTRBCL2
SCHEMBL8309616 0.93 PPARG (0.50) PPARGFFAR1PPARAS1PR1CFTR
SCHEMBL8309618 0.93 PPARG (0.50) PPARGFFAR1PPARAS1PR1CFTR
SCHEMBL8444587 0.92 PPARG (0.51) PPARGFFAR1S1PR1BCL2HTT
SCHEMBL8309782 0.92 PPARG (0.51) PPARGFFAR1PPARAS1PR1BCL2
SCHEMBL8309781 0.92 PPARG (0.51) PPARGFFAR1PPARAS1PR1BCL2
SCHEMBL8305089 0.90 PPARG (0.51) PPARGFFAR1S1PR1HTTMAPT
SCHEMBL8305087 0.90 PPARG (0.51) PPARGFFAR1S1PR1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed